Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$185,862,562
+$18,270,874 QoQ
Shares Held
7,718,545
+29.3% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#68
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $2,905,699,167 across 10 Drug Manufacturers - General names. PFE ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
734,148 | $880,559,208 | |
| 2 | JNJ |
Johnson & Johnson
|
2,205,062 | $560,019,596 | |
| 3 | ABBV |
AbbVie Inc.
|
1,904,997 | $479,373,444 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,913,536 | $245,889,375 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,759,349 | $222,276,152 | |
| 6 | AMGN |
Amgen Inc
|
578,474 | $209,477,004 | |
| 7 | PFE |
Pfizer Inc
This page
|
7,718,545 | $185,862,562 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,794,030 | $103,372,007 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,862,562 | 7,718,545 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $167,591,688 | 5,968,365 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $161,489,148 | 6,485,508 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $242,934,550 | 9,534,323 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $175,541,279 | 7,241,802 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $151,256,284 | 5,969,072 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $183,787,555 | 6,927,537 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $119,659,692 | 4,134,751 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $110,141,870 | 3,936,450 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $121,347,418 | 4,372,880 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $184,382,703 | 6,404,401 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $214,687,152 | 6,472,329 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $285,374,030 | 7,780,099 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $386,943,526 | 9,483,910 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $466,487,524 | 9,103,972 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $445,203,341 | 10,173,751 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $533,259,080 | 10,170,877 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $503,053,073 | 9,717,077 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $566,250,466 | 9,589,339 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $393,181,075 | 9,141,620 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $450,302,288 | 11,499,037 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $405,785,708 | 11,200,268 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $352,609,240 | 9,579,170 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $1,357,641 | 36,993 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $912,919 | 27,918 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $676,593 | 20,729 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||